{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
INN:etidaligide [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT03508947: Phase 1 Interventional Completed Duchenne Muscular Dystrophy
(2018)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT03373786: Phase 1 Interventional Completed Alport Syndrome
(2017)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:cavrotolimod [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:vidutolimod [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT03721978: Phase 3 Interventional Completed Cervical Dysplasia
(2019)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT03140969: Phase 1/Phase 2 Interventional Completed Leber's Congenital Amaurosis
(2017)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:amolimogene bepiplasmid [INN]
Source URL:
Class:
NUCLEIC ACID